| Dr Melanie Ruth Fleischmann, | |
|
1120 Cocoa Ave, Cocoa Family Medicine, Hershey, PA 17033-1712 | |
| (717) 533-4141 | |
| Not Available |
| Full Name | Dr Melanie Ruth Fleischmann |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 1120 Cocoa Ave, Hershey, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215972500 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD429719 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Lancaster, PA | Home health agency |
| St Joseph Medical Center | Reading, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
About 8 percent of people will develop post-traumatic stress disorder at some point in their lives, according to the U.S. Department of Veterans Affairs, yet treatments for this debilitating condition remain limited.
Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher's disease, Fabry's disease, PKU, MPS I (Hurler Syndrome), MPS II (Hunter Syndrome), MPS VI (Maroteaux-Lamy Syndrome), Niemann-Pick disease and Pompe disease.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 2 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
About 8 percent of people will develop post-traumatic stress disorder at some point in their lives, according to the U.S. Department of Veterans Affairs, yet treatments for this debilitating condition remain limited.
Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher's disease, Fabry's disease, PKU, MPS I (Hurler Syndrome), MPS II (Hunter Syndrome), MPS VI (Maroteaux-Lamy Syndrome), Niemann-Pick disease and Pompe disease.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melanie Ruth Fleischmann, 1120 Cocoa Ave, Cocoa Family Medicine, Hershey, PA 17033-1712 Ph: (717) 533-4141 | Dr Melanie Ruth Fleischmann, 1120 Cocoa Ave, Cocoa Family Medicine, Hershey, PA 17033-1712 Ph: (717) 533-4141 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
About 8 percent of people will develop post-traumatic stress disorder at some point in their lives, according to the U.S. Department of Veterans Affairs, yet treatments for this debilitating condition remain limited.
Guidepoint Global, LLC, a leading primary research firm, today announced the launch of their Genetic Disorder Tracker, a monthly longitudinal data release that captures commercial trends, on a worldwide basis, associated with the treatment of eight rare genetic disorders: Gaucher's disease, Fabry's disease, PKU, MPS I (Hurler Syndrome), MPS II (Hunter Syndrome), MPS VI (Maroteaux-Lamy Syndrome), Niemann-Pick disease and Pompe disease.
"A proliferation of complex challenges to development, such as political conflict, economic austerity, and environmental degradation, all demand attention, but should not deflect from recognizing that good health is central to advancing global prosperity," GAVI Alliance CEO Seth Berkley, WHO Director-General Margaret Chan, Global Fund to Fight AIDS, TB and Malaria Executive Director Mark Dybul, World Bank Sector Manager for Health in Latin America Keith Hansen, UNICEF Executive Director Anthony Lake, UNFPA Executive Director Babatunde Osotimehin, and UNAIDS Executive Director Michel Sidibé, write in a Lancet opinion piece examining the post-2015 development agenda.
› Verified 2 days ago
Marium Tariq, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-8521 | |
Justin Tondt, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
James Michael Brian, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
N Benjamin Fredrick, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 845 Fishburn Rd, Hershey, PA 17033 Phone: 717-531-8181 Fax: 717-531-3509 | |
Caryn Michelle Brenner-williams, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 717-531-3817 | |
Stacey Lynn Milunic, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 University Dr, Hershey, PA 17033 Phone: 800-243-1455 | |
Elizabeth Ann Meck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 Cocoa Ave, Hershey, PA 17033 Phone: 717-533-4141 Fax: 717-533-9797 |